Cargando…
Disseminated cutaneous leishmaniasis in a kidney transplant recipient
KEY CLINICAL MESSAGE: In this case of disseminated cutaneous leishmaniasis in our immunosuppressive patient who was a refractor to treatment with intra‐lesion Glucantime® and systemic L‐AmB, considering the good clinical response to oral miltefosine, this drug might be the best treatment option. ABS...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264955/ https://www.ncbi.nlm.nih.gov/pubmed/37323282 http://dx.doi.org/10.1002/ccr3.7549 |
_version_ | 1785058435200450560 |
---|---|
author | Amiri, Rezvan Farrokhnia, Mehrdad Mousavi Mehdiabadi, Fatemeh |
author_facet | Amiri, Rezvan Farrokhnia, Mehrdad Mousavi Mehdiabadi, Fatemeh |
author_sort | Amiri, Rezvan |
collection | PubMed |
description | KEY CLINICAL MESSAGE: In this case of disseminated cutaneous leishmaniasis in our immunosuppressive patient who was a refractor to treatment with intra‐lesion Glucantime® and systemic L‐AmB, considering the good clinical response to oral miltefosine, this drug might be the best treatment option. ABSTRACT: Diagnosis and treatment of leishmaniasis are challenging in immunosuppressed patients. Here, we report a 46‐year‐old male renal transplant recipient with disseminated cutaneous leishmaniasis presenting with multiple lesions on the face and upper extremities 15 years after transplant with a challenging course of treatment with meglumine antimoniate, liposomal amphotericin B, and miltefosine. |
format | Online Article Text |
id | pubmed-10264955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102649552023-06-15 Disseminated cutaneous leishmaniasis in a kidney transplant recipient Amiri, Rezvan Farrokhnia, Mehrdad Mousavi Mehdiabadi, Fatemeh Clin Case Rep Case Report KEY CLINICAL MESSAGE: In this case of disseminated cutaneous leishmaniasis in our immunosuppressive patient who was a refractor to treatment with intra‐lesion Glucantime® and systemic L‐AmB, considering the good clinical response to oral miltefosine, this drug might be the best treatment option. ABSTRACT: Diagnosis and treatment of leishmaniasis are challenging in immunosuppressed patients. Here, we report a 46‐year‐old male renal transplant recipient with disseminated cutaneous leishmaniasis presenting with multiple lesions on the face and upper extremities 15 years after transplant with a challenging course of treatment with meglumine antimoniate, liposomal amphotericin B, and miltefosine. John Wiley and Sons Inc. 2023-06-13 /pmc/articles/PMC10264955/ /pubmed/37323282 http://dx.doi.org/10.1002/ccr3.7549 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Report Amiri, Rezvan Farrokhnia, Mehrdad Mousavi Mehdiabadi, Fatemeh Disseminated cutaneous leishmaniasis in a kidney transplant recipient |
title | Disseminated cutaneous leishmaniasis in a kidney transplant recipient |
title_full | Disseminated cutaneous leishmaniasis in a kidney transplant recipient |
title_fullStr | Disseminated cutaneous leishmaniasis in a kidney transplant recipient |
title_full_unstemmed | Disseminated cutaneous leishmaniasis in a kidney transplant recipient |
title_short | Disseminated cutaneous leishmaniasis in a kidney transplant recipient |
title_sort | disseminated cutaneous leishmaniasis in a kidney transplant recipient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264955/ https://www.ncbi.nlm.nih.gov/pubmed/37323282 http://dx.doi.org/10.1002/ccr3.7549 |
work_keys_str_mv | AT amirirezvan disseminatedcutaneousleishmaniasisinakidneytransplantrecipient AT farrokhniamehrdad disseminatedcutaneousleishmaniasisinakidneytransplantrecipient AT mousavimehdiabadifatemeh disseminatedcutaneousleishmaniasisinakidneytransplantrecipient |